Neue Therapieoption für das fortgeschrittene HER2-positive MammakarzinomNew treatment options for advanced HER2-positive breast cancer

被引:0
|
作者
D. Forstmeyer
机构
[1] Universitätsklinikum Leipzig,Universitäres Krebszentrum Leipzig (UCCL)
来源
Der Onkologe | 2013年 / 19卷 / 1期
关键词
D O I
10.1007/s00761-012-2375-y
中图分类号
学科分类号
摘要
引用
收藏
页码:60 / 61
页数:1
相关论文
共 50 条
  • [1] Neue Option für das HER2-positive Magenkarzinom
    Miriam Sonnet
    Gastro-News, 2023, 10 (2) : 67 - 67
  • [2] HER2-positive advanced breast cancer
    Robert, Nicholas J.
    Favret, Anne M.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2007, 21 (02) : 293 - +
  • [3] Treatment of HER2-positive breast cancer
    Figueroa-Magalhaes, Maria Cristina
    Jelovac, Danijela
    Connolly, Roisin M.
    Wolff, Antonio C.
    BREAST, 2014, 23 (02): : 128 - 136
  • [4] HER2-positive advanced breast cancer treatment in 2020
    Cesca, Marcelle G.
    Vian, Lucas
    Cristovao-Ferreira, Sofia
    Ponde, Noam
    de Azambuja, Evandro
    CANCER TREATMENT REVIEWS, 2020, 88
  • [5] Current neoadjuvant treatment options for HER2-positive breast cancer
    Abdel-Razeq, Hikmat
    Marei, Lina
    BIOLOGICS-TARGETS & THERAPY, 2011, 5 : 87 - 94
  • [6] HER2-positive breast cancer
    Loibl, Sibylle
    Gianni, Luca
    LANCET, 2017, 389 (10087): : 2415 - 2429
  • [7] Advanced HER2-positive breast cancer: Overcoming treatment resistance
    Rimawi, M.
    CANCER RESEARCH, 2019, 79 (04)
  • [8] New Treatment Option for advanced HER2-positive Breast Cancer
    Forstmeyer, D.
    ONKOLOGE, 2013, 19 (01): : 60 - 61
  • [9] Treatment of advanced HER2-positive breast cancer: 2018 and beyond
    Ponde, Noam
    Brandao, Mariana
    El-Hachem, Georges
    Werbrouck, Emilie
    Piccart, Martine
    CANCER TREATMENT REVIEWS, 2018, 67 : 10 - 20
  • [10] Fulvestrant in the treatment of HER2-positive advanced breast cancer (ABC)
    Robertson, J. F.
    Steger, G. G.
    Neven, P.
    Barni, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)